中财网 中财网股票行情
泽璟制药-U(688266)财务分析指标    年份：
截止日期2025-12-312025-09-302025-06-302025-03-312024-12-31
营业总收入(万元)81048.4759344.0137565.0316764.2053295.44
营业收入(万元)81048.4759344.0137565.0316764.2053295.44
营业总成本(万元)102938.9972548.6147516.8322489.1773065.69
营业成本(万元)7763.385694.583882.091946.783699.14
净利润(万元)-16251.96-9395.40-7322.03-2812.33-14635.54
归属于母公司的净利润(万元)-16294.62-9341.62-7280.35-2826.22-13783.08
营业利润(万元)-16801.32-9676.26-7673.12-3001.70-15504.32
利润总额(万元)-16865.48-9831.96-7741.50-3031.70-15504.78
少数股东损益(万元)-218.06-218.06-276.64-105.11-1246.75
基本每股收益(元)-0.62(元)-0.35(元)-0.28(元)-0.11(元)-0.52(元)
稀释每股收益(元)-0.62(元)-0.35(元)-0.28(元)-0.11(元)-0.52(元)
非经常性损益(万元)--2726.28--2181.873332.95
扣除非经常性损益后净利润(万元)-19785.52-12067.90-10264.14-5008.10-17116.03
总资产(万元)296918.56301337.74299920.34291782.39300461.43
总负债(万元)188873.74186436.36182258.79169409.40175201.37
归属于母公司股东权益合计(万元)108044.82114901.39117661.54122601.30125385.79
股东权益合计(万元)108044.82114901.39117661.54122372.99125260.05
实收资本(股本)(万元)26470.8226470.8226470.8226470.8226470.82
资本公积(万元)310947.65310947.65311634.44312064.51312036.66
未分配利润(万元)-227968.87-221015.87-218954.60-214500.47-211674.25
经营活动产生的现金流量净额(万元)-2878.20-1673.39-1702.03-625.323820.45
经营活动现金流入小计(万元)105548.1676614.1647514.3221678.1487282.90
经营活动现金流出小计(万元)108426.3678287.5549216.3522303.4683462.45
投资活动产生的现金流量净额(万元)-5563.44-6655.37-6234.26-2663.07-184510.14
投资活动现金流入小计(万元)12583.236594.351737.32717.74121708.86
投资活动现金流出小计(万元)18146.6713249.727971.583380.81306219.00
筹资活动产生的现金流量净额(万元)-750.10-68.502591.28-3179.61-5131.64
筹资活动现金流入小计(万元)112688.2561602.1143152.1114132.19128861.85
筹资活动现金流出小计(万元)113438.3561670.6140560.8317311.80133993.49
期末现金及现金等价物余额(万元)12465.7713276.5316336.1815257.6321726.55
最后修改日期2026-03-282025-11-012025-08-222025-04-212025-04-21
↑返回页顶↑

转至泽璟制药-U（688266）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。